114 related articles for article (PubMed ID: 6177128)
21. Serotyping and pathogenicity of Erysipelothrix strains isolated from tonsils of slaughter pigs in Thailand.
Takahashi T; Sunama P; Satra J; Cholsindhu N; Kongthon S; Jitnupong W; Yamamoto K; Kijima M; Furuuchi S
J Vet Med Sci; 1999 Sep; 61(9):1007-11. PubMed ID: 10535518
[TBL] [Abstract][Full Text] [Related]
22. Pathogenic characterization of Erysipelothrix rhusiopathiae Met-203 type SpaA strains from chronic and subacute swine erysipelas in Japan.
Uchiyama M; Shimazaki Y; Isshiki Y; Kojima A; Hirano F; Yamamoto K; Kijima M; Nagai H
J Vet Med Sci; 2017 Jan; 79(1):18-21. PubMed ID: 27773881
[TBL] [Abstract][Full Text] [Related]
23. [Neuraminidase activity of the L forms of Erysipelothrix rhusiopathiae].
Nikolov P; Todorov TKh; Abrashev I
Acta Microbiol Virol Immunol (Sofiia); 1977; 5():18-21. PubMed ID: 610397
[No Abstract] [Full Text] [Related]
24. The protection of mice by a specific anti-Erysipelothrix insidiosa-neuraminidase-antiserum against Erysipelothrix insidiosa infection.
Müller HE
Med Microbiol Immunol; 1974 Jun; 159(4):301-8. PubMed ID: 4212441
[No Abstract] [Full Text] [Related]
25. Isolation of acriflavine resistant Erysipelothrix rhusiopathiae from slaughter pigs in Japan.
Makino S; Ishizaki H; Shirahata T; Fujiwara S; Sawada T
J Vet Med Sci; 1998 Sep; 60(9):1017-9. PubMed ID: 9795903
[TBL] [Abstract][Full Text] [Related]
26. [Antigenic structure of the causative agent and immunodiagnosis of erysipeloid].
Denisov GI; Karal'nik BV; Chaĭkovskiĭ VT
Zh Mikrobiol Epidemiol Immunobiol; 1987 Feb; (2):81-6. PubMed ID: 3554852
[No Abstract] [Full Text] [Related]
27. Protective activity of the purified protein antigen of Erysipelothrix rhusiopathiae in pigs.
Yamazaki Y; Sato H; Sakakura H; Shigeto K; Nakano K; Saito H; Maehara N
Zentralbl Veterinarmed B; 1999 Feb; 46(1):47-55. PubMed ID: 10085773
[TBL] [Abstract][Full Text] [Related]
28. Properties of a protective protein antigen of Erysipelothrix rhusiopathiae.
Timoney JF; Groschup MM
Vet Microbiol; 1993 Nov; 37(3-4):381-7. PubMed ID: 8116193
[TBL] [Abstract][Full Text] [Related]
29. Effects of antibiotics on the immune system of animals. I. Mouse experiments with the low-virulence VR2 strain of Erysipelothrix rhusiopathiae.
Tu TD
Acta Vet Acad Sci Hung; 1981; 28(3):297-307. PubMed ID: 7258018
[No Abstract] [Full Text] [Related]
30. Erythrocyte reagents in the study of Erysipelothrix antigens.
Karalnik BV; Denisov GI
J Hyg Epidemiol Microbiol Immunol; 1986; 30(4):431-9. PubMed ID: 3805715
[TBL] [Abstract][Full Text] [Related]
31. Detection of Erysipelothrix rhusiopathiae in clinical and environmental samples.
Fidalgo SG; Riley TV
Methods Mol Biol; 2004; 268():199-205. PubMed ID: 15156031
[TBL] [Abstract][Full Text] [Related]
32. Erysipelothrix rhusiopathiae.
Wang Q; Chang BJ; Riley TV
Vet Microbiol; 2010 Jan; 140(3-4):405-17. PubMed ID: 19733019
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the protective efficacy of four newly identified surface proteins of Erysipelothrix rhusiopathiae.
Zhu W; Wu C; Kang C; Cai C; Wang Y; Li J; Zhang Q; Sun X; Jin M
Vaccine; 2018 Dec; 36(52):8079-8083. PubMed ID: 30446176
[TBL] [Abstract][Full Text] [Related]
34. [Erysipelothrix rhusiopathiae--a cause of erysipeloid and endocarditis].
Hjetland R; Søgnen E; Våge V
Tidsskr Nor Laegeforen; 1995 Sep; 115(22):2780-2. PubMed ID: 7570494
[TBL] [Abstract][Full Text] [Related]
35. Erysipeloid lesions caused by Erysipelothrix rhusiopathiae in a dog: clinical and histopathological findings, molecular diagnosis and treatment.
Marshall KR; Walton SA; Boyd M; Bishop B; Wellehan J; Craft W; Santoro D
Vet Dermatol; 2019 Oct; 30(5):434-e134. PubMed ID: 31364229
[TBL] [Abstract][Full Text] [Related]
36. Use of the protective antigen of Erysipelothrix rhusiopathiae in the enzyme-linked immunosorbent assay and latex agglutination.
Sato H; Yamazaki Y; Tsuchiya K; Aoyama T; Akaba N; Suzuki T; Yokoyama A; Saito H; Maehara N
Zentralbl Veterinarmed B; 1998 Sep; 45(7):407-20. PubMed ID: 9780828
[TBL] [Abstract][Full Text] [Related]
37. Antibiotics in treatment of experimental erysipelothrix rhusiopathiae infection of mice; use of chlortetracycline(aureomycin), oxytetracycline (terramycin), and erythromycin (ilotycin), with comments on treatment of the infection in human beings.
KLAUDER JV; RULE AM
AMA Arch Derm Syphilol; 1954 May; 69(5):570-6. PubMed ID: 13147564
[No Abstract] [Full Text] [Related]
38. Cross protection of mice and swine given live-organism vaccine against challenge exposure with strains of Erysipelothrix rhusiopathiae representing ten serovars.
Sawada T; Takahashi T
Am J Vet Res; 1987 Jan; 48(1):81-4. PubMed ID: 3826847
[TBL] [Abstract][Full Text] [Related]
39. Isolation and purification of a protective protein antigen of Erysipelothrix rhusiopathiae.
Sato H; Miyazaki H; Sakakura H; Suzuki T; Saito H; Maehara N
Zentralbl Veterinarmed B; 1999 Mar; 46(2):73-84. PubMed ID: 10216450
[TBL] [Abstract][Full Text] [Related]
40. Preparation and partial characterization of monoclonal antibodies against the protective protein antigen of Erysipelothrix rhusiopathiae.
Sato H; Yamazaki Y; Kodaira A; Saito H; Maehara N
Zentralbl Veterinarmed B; 1999 Mar; 46(2):85-92. PubMed ID: 10216451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
